{"pressReleaseArticle":{"contentWrapper":{"title":"New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration","intro":"","publishDateTime":"20-02-2019 00:00:00","publishDate":"February 20 2019","forInvestorsAndMediaOnlyText":"","shortDescription":"New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration","image":null,"downloadLink":null,"tags":[]},"components":[{"type":"rich-text","text":"<p>Montreal, Canada and London, UK, February 20, 2019. The NEOMED Institute (NEOMED), GlaxoSmithKline Inc. (GSK), the Centre Hospitalier de l'Université de Montréal (CHUM) Research Centre and University College London (UCL) are pleased to announce that they have entered into a strategic collaboration to explore the potential of a newly identified target for HIV immune therapy and cure.</p>\n<p>This will be a truly collaborative effort in which all parties will contribute their resources and expertise to the project. A joint steering committee with representation by all parties will oversee all aspects of the research to be conducted in the laboratories of the CHUM Research Centre and UCL during the next two years. Additionally, the project will be funded by both NEOMED and GSK through the NEOMED GSK Discovery Fund established in 2017 and intended to accelerate novel science and technology discoveries emanating from Quebec (Canada) universities and research centres.</p>\n<p>“This international collaboration truly reflects NEOMED's mission to help translate innovative scientific ideas into the medicines of the future,” said Donald Olds, President &amp; CEO of the NEOMED Institute.</p>\n<p>“By working with others in an open and collaborative way, we can achieve so much more for patients and the life sciences sector than we could hope to do alone,” said Yoo-Seok (YS) Hong, President, Canada Pharmaceuticals, GSK. “We are proud to work in collaboration, along with NEOMED, with two well known academic institutions to help progress the work on a very exciting target with leading researchers in their field.”</p>\n<p>The value and potential for this new target for HIV immune therapy and cure was independently identified through different approaches in the laboratories of Dr. Petronela Ancuta at the CHUM Research Centre and Dr. Ariberto Fassati at UCL and became the framework of a well-established collaboration between these two researchers. “Although very preliminary, the evidence that we have been able to generate together suggests the potential ability to significantly decrease HIV replication and persistence,” mentions Dr. Ancuta, Full Research Professor, Immunopathology at the CHUM Research Centre.&nbsp;“We are very encouraged by our work to date and even more so by the belief in and support from both NEOMED and GSK that will help accelerate our further research on this target and its potential impact on HIV,” added Dr. Fassati, Professor, Infection &amp; Immunity at UCL.</p>\n<p><strong>About the NEOMED Institute (NEOMED)</strong></p>\n<p>The NEOMED Institute is a successful and innovative Canadian not-for-profit R&amp;D organization whose mission is to enable and accelerate the commercialization of life science discoveries. NEOMED Institute operates two complementary and integrated divisions: NEOMED Therapeutics in-licenses promising scientific discoveries from Canadian university centres and research institutes and then funds and develops these programs to stages that are attractive for partnering or stand-alone financing; and NEOMED Innovation Centre operates a world-class life sciences ecosystem in Montreal, Quebec hosting 32 life sciences companies employing over 350 people who operate in our two state-of-the-art R&amp;D centres. The NEOMED Institute is funded by pharmaceutical partners, Quebec’s Ministry of the Economy and Innovation, and the Networks of Centres of Excellence of Canada. For more information, please visit: <span style=\"text-decoration: underline;\"><a href=\"http://www.neomed.ca\">www.neomed.ca</a></span></p>\n<p><strong>About GlaxoSmithKline Inc. (GSK)</strong></p>\n<p>GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. Employing approximately 2,000 full time employees across Canada, GSK has two divisional headquarters in Mississauga, Ontario and Laval Quebec, and an administrative office in Quebec City. Since 2001, GSK has invested more than $2 billion in Canadian pharmaceutical and vaccine R&amp;D, ranking it among the top 10 contributors to R&amp;D in Canada across all industries. For further information, please visit www.ca.gsk.com.</p>\n<p><strong>About the CHUM Research Centre</strong></p>\n<p>The CHUM Research Centre is one of North America’s leading hospital research centres. It strives to improve adult health through a research continuum covering such disciplines as the fundamental sciences, clinical research and public health. Over 1,861 people work at the CHUM Research Centre, including 542 scientists and 719 students and research assistants, please visit: <span style=\"text-decoration: underline;\"><a href=\"http://www.chumontreal.qc.ca/crchum\">www.chumontreal.qc.ca/crchum</a></span></p>\n<p><strong>About University College London (UCL)</strong></p>\n<p>UCL was founded in 1826. We were the first English university established after Oxford and Cambridge, the first to open up university education to those previously excluded from it, and the first to provide systematic teaching of law, architecture and medicine. We are among the world's top universities, as reflected by performance in a range of international rankings and tables. UCL currently has over 41,500 students from 150 countries and over 12,500 staff. Our annual income is more than £1 billion.</p>\n<p><a href=\"http://www.ucl.ac.uk\">www.ucl.ac.uk</a> | Follow us on Twitter <a href=\"https://twitter.com/uclnews\">@uclnews</a> | Watch our YouTube channel <span style=\"text-decoration: underline;\">YouTube.com/UCLTV</span></p>\n<p><strong>NEOMED Enquiries:<br></strong>Shirley Robinet<br>Communications Coordinator<br>+1 514-375-3334 ext. 111<br><a href=\"mailto:srobinet@neomed.ca\">srobinet@neomed.ca</a></p>\n<p><strong>CHUM Research Centre Enquiries:<br></strong>Jacinthe Ouellette<br>Communication advisor<br>514-890-8000, ext. 23675<br><a href=\"mailto:jacinthe.ouellette.chum@ssss.gouv.qc.ca\">jacinthe.ouellette.chum@ssss.gouv.qc.ca</a></p>\n<p><strong>UCL Enquiries:<br></strong>Chris Lane<br>Media Relations Manager, UCL Medical Sciences<br>Office: +44 (0) 20 7679 9222<br>Mob: +44 (0) 7717 728 648<br><a href=\"mailto:chris.lane@ucl.ac.uk\">chris.lane@ucl.ac.uk</a></p>","useGreyBackground":false,"fullWidth":false},{"type":"varied-signpost-grid","title":"Find more about us","layoutPattern":1,"pages":[{"title":"Company","content":"We unite science, technology and talent to get ahead of disease together","image":{"src":"/media/ksueo3le/immuno-oncology-science-image.jpg?width=480&height=270&format=webp&quality=100&v=1dbf19a8b311970","alt":"3D rendering of immuno-oncology cells","darkModeSrc":"/media/ksueo3le/immuno-oncology-science-image.jpg?width=480&height=270&format=webp&quality=90&v=1dbf19a8b311970"},"link":{"text":"Company","href":"/en-ca/company/","openInNewWindowText":null}},{"title":"Press releases","content":"Keep up to date with our news and recent announcements","image":{"src":"/media/m0ffxymm/gskh_3_2022_comspc_19_hess.jpg?rxy=0.41046277665995978,0.35347432024169184&width=480&height=270&format=webp&quality=100&v=1dbf19a8f3897f0","alt":"Two blurred figure in a large room.","darkModeSrc":"/media/m0ffxymm/gskh_3_2022_comspc_19_hess.jpg?rxy=0.41046277665995978,0.35347432024169184&width=480&height=270&format=webp&quality=90&v=1dbf19a8f3897f0"},"link":{"text":"Press releases","href":"/en-ca/media/press-releases/","openInNewWindowText":null}}],"hidePageDescription":false,"useGreyBackground":false}]},"id":6453,"docCheckLogout":null,"pageType":"pressReleasePage","languageCode":"en-CA","theme":"light","breadcrumb":{"ariaLabel":"Breadcrumb","links":[{"text":"Home","href":"/en-ca/","openInNewWindowText":null},{"text":"Media","href":"/en-ca/media/","openInNewWindowText":null},{"text":"Press releases","href":"/en-ca/media/press-releases/","openInNewWindowText":null},{"text":"New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration","href":"/en-ca/media/press-releases/new-target-for-hiv-immune-therapy-and-cure-to-be-explored-by-trans-atlantic-industry-academia-collaboration/","openInNewWindowText":null}]},"pageName":"New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration","topNav":{"homeLink":{"text":"GSK Homepage","href":"/en-ca/","openInNewWindowText":null},"topBar":{"currentLocation":{"isGlobal":false,"text":"Canada (EN/FR)"},"languageSelector":{"currentLanguage":"English","currentLanguageMobile":"EN","selectableLanguages":[{"opensInNewWindow":"Opens in a new window","desktopName":"English","mobileName":"EN","code":"/en-ca/","target":null},{"opensInNewWindow":"Opens in a new window","desktopName":"Français","mobileName":"FR","code":"/fr-ca/","target":null}]},"darkModeSwitch":{"text":"Dark Mode","tooltipText":"<p>Switch to dark mode to head towards a more sustainable world together. <a href=\"/en-ca/digital-sustainability/\" title=\"Digital sustainability\">More info</a>.</p>"},"globalSiteLink":{"text":"Global","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"locationSelector":{"text":"Location selector","href":"/en-ca/locations/","openInNewWindowText":null},"healthCareLink":{"text":"Healthcare professionals","href":"https://gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"contactUs":{"text":"Contact us","href":"/en-ca/contact-us/","openInNewWindowText":null},"search":"Search","backToMain":"Back to main","menu":"Menu","closeMenu":"Close menu","animationsToggleModel":{"enable":true,"activeText":"Pause video","inactiveText":"Play video"}},"nodes":[{"tooltip":null,"hasBorderRight":false,"title":"Company","url":"/en-ca/company/","nodes":[{"title":"Purpose, strategy and culture","url":"/en-ca/company/purpose-strategy-and-culture/","nodes":[],"isActive":false},{"title":"At a glance","url":"/en-ca/company/at-a-glance/","nodes":[],"isActive":false},{"title":"Canada leadership team","url":"/en-ca/company/canada-leadership-team/","nodes":[],"isActive":false},{"title":"Policies","url":"/en-ca/company/policies/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Global Outstanding people","image":{"src":"/media/l20f4brn/navthumb-web09-header-gskh_2_2022_smtspc_37_hess.jpg?rxy=0.355,0.36888888888888888&width=329&height=185&format=webp&quality=100&v=1dbf19a8f7504b0","alt":"Man smiling during a meeting","darkModeSrc":"/media/l20f4brn/navthumb-web09-header-gskh_2_2022_smtspc_37_hess.jpg?rxy=0.355,0.36888888888888888&width=329&height=185&format=webp&quality=90&v=1dbf19a8f7504b0"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/company/outstanding-people/","target":"_blank","openInNewWindowText":"Opens in a new window"}},{"text":"Global policy positions","image":{"src":"/media/zx5kpb4m/gsk_texture_fluid_03_a_cmyk_web-size.jpg?width=329&height=185&format=webp&quality=100&v=1dbf19a9142e6e0","alt":"Orange texture","darkModeSrc":"/media/zx5kpb4m/gsk_texture_fluid_03_a_cmyk_web-size.jpg?width=329&height=185&format=webp&quality=90&v=1dbf19a9142e6e0"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/company/policy-positions","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Innovation","url":"/en-ca/innovation/","nodes":[{"title":"Therapeutic areas","url":"/en-ca/innovation/therapeutic-areas/","nodes":[],"isActive":false},{"title":"Trials","url":"/en-ca/innovation/trials/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Global pipeline","image":{"src":"/media/xskjorin/ware_3_2022_prodqc_14_hess.jpg?width=329&height=185&format=webp&quality=100&v=1dbf19a91879100","alt":"Science experiment","darkModeSrc":"/media/xskjorin/ware_3_2022_prodqc_14_hess.jpg?width=329&height=185&format=webp&quality=90&v=1dbf19a91879100"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/innovation/pipeline/","target":"_blank","openInNewWindowText":"Opens in a new window"}},{"text":"Global Behind the science magazine","image":{"src":"/media/ksueo3le/immuno-oncology-science-image.jpg?width=329&height=185&format=webp&quality=100&v=1dbf19a8b311970","alt":"3D rendering of immuno-oncology cells","darkModeSrc":"/media/ksueo3le/immuno-oncology-science-image.jpg?width=329&height=185&format=webp&quality=90&v=1dbf19a8b311970"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/behind-the-science-magazine/","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Products","url":"/en-ca/products/","nodes":[{"title":"Products A-Z","url":"/en-ca/products/products-a-z/","nodes":[],"isActive":false},{"title":"Stiefel - Dermatology","url":"/en-ca/products/stiefel-dermatology/","nodes":[],"isActive":false},{"title":"Report a possible side effect","url":"/en-ca/products/report-a-possible-side-effect/","nodes":[],"isActive":false},{"title":"Patient Support and Healthcare Support Services","url":"/en-ca/products/patient-support-and-healthcare-support-services/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Report a possible side effect","image":{"src":"/media/0otczyps/web03-header-stvg_2_2022_port_5_hess_nav.jpg?rxy=0.53,0.48444444444444446&width=329&height=185&format=webp&quality=100&v=1dbf19a8dba8370","alt":"Woman in a labcoat smiling at the camera","darkModeSrc":"/media/0otczyps/web03-header-stvg_2_2022_port_5_hess_nav.jpg?rxy=0.53,0.48444444444444446&width=329&height=185&format=webp&quality=90&v=1dbf19a8dba8370"},"link":{"text":"Featured section","href":"/en-ca/products/report-a-possible-side-effect/","openInNewWindowText":null}},{"text":"GSKPro","image":{"src":"/media/i5mft2xn/navthumb_stvg_03_2022_port_32_eagle_orange-1.jpg?rxy=0.48,0.23555555555555555&width=329&height=185&format=webp&quality=100&v=1dbf19a8e994ab0","alt":"Two people hanging out together in front of an orange background","darkModeSrc":"/media/i5mft2xn/navthumb_stvg_03_2022_port_32_eagle_orange-1.jpg?rxy=0.48,0.23555555555555555&width=329&height=185&format=webp&quality=90&v=1dbf19a8e994ab0"},"link":{"text":"Featured website","href":"https://gskpro.com/en-ca/","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":true,"title":"Responsibility","url":"/en-ca/responsibility/","nodes":[{"title":"Inclusion","url":"/en-ca/responsibility/inclusion/","nodes":[],"isActive":false},{"title":"Ethical standards","url":"/en-ca/responsibility/ethical-standards/","nodes":[{"title":"Engaging with healthcare professionals","url":"/en-ca/responsibility/ethical-standards/engaging-with-healthcare-professionals/","nodes":[],"isActive":false},{"title":"Transparency reporting","url":"/en-ca/responsibility/ethical-standards/transparency-reporting/","nodes":[],"isActive":false},{"title":"Medical grants","url":"/en-ca/responsibility/ethical-standards/medical-grants/","nodes":[],"isActive":false}],"isActive":false},{"title":"Charitable investments in Canada","url":"/en-ca/responsibility/charitable-investments-in-canada/","nodes":[],"isActive":false},{"title":"Accessibility","url":"/en-ca/responsibility/accessibility/","nodes":[{"title":"GSK’s Multi-Year Accessibility Plan","url":"/en-ca/responsibility/accessibility/gsk-s-multi-year-accessibility-plan/","nodes":[],"isActive":false}],"isActive":false},{"title":"Patient group funding","url":"/en-ca/responsibility/patient-group-funding/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Ethical standards","image":{"src":"/media/uxlkxzrj/ware_3_2022_prodqc_38_hess-1.jpg?width=329&height=185&format=webp&quality=100&v=1dbf19a8db07150","alt":"Group working together in a lab","darkModeSrc":"/media/uxlkxzrj/ware_3_2022_prodqc_38_hess-1.jpg?width=329&height=185&format=webp&quality=90&v=1dbf19a8db07150"},"link":{"text":"Featured section","href":"/en-ca/responsibility/ethical-standards/","openInNewWindowText":null}},{"text":"Global responsibility","image":{"src":"/media/olhgq5am/stvg_2_2022_smtlab_2_hess-1920x1080px.jpeg?rxy=0.41851106639839036,0.37764350453172207&width=329&height=185&format=webp&quality=100&v=1dbf19a8dc8db50","alt":"Man adjusting glasses working on a computer","darkModeSrc":"/media/olhgq5am/stvg_2_2022_smtlab_2_hess-1920x1080px.jpeg?rxy=0.41851106639839036,0.37764350453172207&width=329&height=185&format=webp&quality=90&v=1dbf19a8dc8db50"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/responsibility/","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Media","url":"/en-ca/media/","nodes":[{"title":"Press releases","url":"/en-ca/media/press-releases/","nodes":[],"isActive":true},{"title":"Media contacts","url":"/en-ca/media/media-contacts/","nodes":[],"isActive":false},{"title":"Resource library","url":"/en-ca/media/resource-library/","nodes":[],"isActive":false}],"isActive":true,"promos":[{"text":"Global press releases","image":{"src":"/media/zyvhqfdo/gsk-house-view.jpg?width=329&height=185&format=webp&quality=100&v=1dbf19a9120dff0","alt":"Artwork in GSK Building","darkModeSrc":"/media/zyvhqfdo/gsk-house-view.jpg?width=329&height=185&format=webp&quality=90&v=1dbf19a9120dff0"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/media/press-releases/","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Careers","url":"/en-ca/careers/","nodes":[{"title":"Life at GSK","url":"/en-ca/careers/life-at-gsk/","nodes":[],"isActive":false},{"title":"Experienced professionals","url":"/en-ca/careers/experienced-professionals/","nodes":[],"isActive":false},{"title":"Early careers","url":"/en-ca/careers/early-careers/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Global how we hire","image":{"src":"/media/sbrno3h2/gsk_rix_24_10_18_p_d2_s4_064-how-we-hire-1920x960px.jpg?rxy=0.579476861167002,0.32661290322580644&width=329&height=185&format=webp&quality=100&v=1dbf19a8f7fb310","alt":"People talking together in a meeting","darkModeSrc":"/media/sbrno3h2/gsk_rix_24_10_18_p_d2_s4_064-how-we-hire-1920x960px.jpg?rxy=0.579476861167002,0.32661290322580644&width=329&height=185&format=webp&quality=90&v=1dbf19a8f7fb310"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/careers/how-we-hire/","target":"_blank","openInNewWindowText":"Opens in a new window"}},{"text":"Global future leaders program","image":{"src":"/media/vgal0nno/gskh-2-2022-smtspc-11-hess-future-leaders-graduate-programme-1920x960px.jpg?rxy=0.42655935613682094,0.3911290322580645&width=329&height=185&format=webp&quality=100&v=1dbf19a8f2d4d50","alt":"Two people conversing together in an office","darkModeSrc":"/media/vgal0nno/gskh-2-2022-smtspc-11-hess-future-leaders-graduate-programme-1920x960px.jpg?rxy=0.42655935613682094,0.3911290322580645&width=329&height=185&format=webp&quality=90&v=1dbf19a8f2d4d50"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/careers/early-talent/future-leaders-graduate-programme","target":"_blank","openInNewWindowText":"Opens in a new window"}}]}],"skipToContent":null,"skipToSearch":null,"typeaheadSearch":{"apiEndpoint":"api/search/typeahead?siteContainerId=5769","searchFieldPlaceholderText":"Enter a search term...","searchPage":"/en-ca/search/","ariaLabel":"Submit form"},"ariaLabel":"Global navigation"},"footer":{"logo":null,"copyrightText":"<p>This website is intended for visitors looking for information on GSK Canada. Other market sites can be reached by visiting <a href=\"/en-ca/locations/\" title=\"Locations\">our location selector</a>.</p>\n<p>© 2001-2026 GSK plc. All rights reserved. Trademarks are owned by or licensed to the GSK group of companies.</p>\n<p>GSK plc. Registered in England and Wales No. 3888792.</p>\n<p>GlaxoSmithKline Inc. <span class=\"fs-4 fw-light text-success\">100 Milverton Drive, Suite 800, Mississauga, ON L5R 4H1</span></p>","modernSlaveryStatement":{"name":"GSK Modern Slavery Act Statement 2023","url":"/media/iwinetmy/modern-slavery-act-statement-2023.pdf","fileExtension":"PDF","fileSize":"154.2KB","type":"file","target":"_blank","openInNewWindowText":"Opens in a new window"},"sections":{"socialMedia":{"columnTitle":"Follow us on:","socialMediaItems":[{"globalLink":{"text":null,"href":"https://twitter.com/gskca","openInNewWindowText":null},"localLink":null,"ariaLabel":"Follow us on X","customIcon":null,"showPopupMenu":false,"type":"X"},{"globalLink":{"text":null,"href":"https://www.facebook.com/GSK","openInNewWindowText":null},"localLink":null,"ariaLabel":"Follow us on Facebook","customIcon":null,"showPopupMenu":false,"type":"Facebook"},{"globalLink":{"text":null,"href":"http://www.youtube.com/GSK","openInNewWindowText":null},"localLink":null,"ariaLabel":"Follow us on Youtube","customIcon":null,"showPopupMenu":false,"type":"Youtube"},{"globalLink":{"text":null,"href":"http://www.linkedin.com/company/glaxosmithkline","openInNewWindowText":null},"localLink":null,"ariaLabel":"Follow us on LinkedIn","customIcon":null,"showPopupMenu":false,"type":"LinkedIn"},{"globalLink":{"text":null,"href":"https://www.instagram.com/gsk/","openInNewWindowText":null},"localLink":null,"ariaLabel":"Follow us on Instagram","customIcon":null,"showPopupMenu":false,"type":"Instagram"}]},"columns":[{"columnTitle":"GSK websites","links":[{"text":"GSK Global website","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Market website selector","href":"/en-ca/locations/","openInNewWindowText":null},{"text":"Global Behind the science magazine","href":"https://www.gsk.com/en-gb/behind-the-science/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"GSKPro for healthcare professionals","href":"https://gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"GSK Medical for healthcare professionals","href":"https://medical.gsk.com/en-ca/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"ViiV Healthcare","href":"https://viivhealthcare.com/en-ca/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Supplier website","href":"https://supplier.gsk.com/","target":"_blank","openInNewWindowText":"Opens in a new window"}]},{"columnTitle":"Quick links","links":[{"text":"Company","href":"/en-ca/company/","openInNewWindowText":null},{"text":"Innovation","href":"/en-ca/innovation/","openInNewWindowText":null},{"text":"Products","href":"/en-ca/products/","openInNewWindowText":null},{"text":"Responsibility","href":"/en-ca/responsibility/","openInNewWindowText":null},{"text":"Media","href":"/en-ca/media/","openInNewWindowText":null},{"text":"Careers","href":"/en-ca/careers/","openInNewWindowText":null}]},{"columnTitle":"Get in touch","links":[{"text":"Contact us","href":"/en-ca/contact-us/","openInNewWindowText":null},{"text":"Report a possible side effect","href":"/en-ca/products/report-a-possible-side-effect/","openInNewWindowText":null},{"text":"GSK Speak up","href":"https://www.gsk.com/speakup","target":"_blank","openInNewWindowText":"Opens in a new window"}]}]},"bottomLinks":[{"text":"Accessibility","href":"/en-ca/responsibility/accessibility/","target":"_parent","openInNewWindowText":"Opens in a new window"},{"text":"Terms of use","href":"/en-ca/terms-of-use/","target":"_parent","openInNewWindowText":"Opens in a new window"},{"text":"Cookie policy","href":"/en-ca/cookie-policy/","target":"_parent","openInNewWindowText":"Opens in a new window"},{"text":"Privacy notice","href":"https://privacy.gsk.com/en-ca/privacy-notice/general/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Sitemap","href":"/en-ca/sitemap/","openInNewWindowText":null}],"continueToLink":null,"legalApprovalText":""},"sharing":{"description":"New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration","og":[{"property":"og:title","content":"New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration"},{"property":"og:description","content":"New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration"},{"property":"og:image","content":"https://ca.gsk.com/media/rsznn1hu/packing2.jpg?width=600&format=webp&quality=100&v=1dbf19a78b5ce80"},{"property":"og:url","content":"https://ca.gsk.com/en-ca/media/press-releases/new-target-for-hiv-immune-therapy-and-cure-to-be-explored-by-trans-atlantic-industry-academia-collaboration/"}],"twitter":[{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:site","content":"@gsk"},{"name":"twitter:title","content":"New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration"},{"name":"twitter:description","content":"New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration"},{"name":"twitter:image","content":"https://ca.gsk.com/media/rsznn1hu/packing2.jpg?width=600&format=webp&quality=100&v=1dbf19a78b5ce80"},{"name":"twitter:url","content":"https://ca.gsk.com/en-ca/media/press-releases/new-target-for-hiv-immune-therapy-and-cure-to-be-explored-by-trans-atlantic-industry-academia-collaboration"}]},"stickyShare":null,"exitSitePreferences":{"popupEnabled":true,"title":"You are leaving our website","texts":"<p><span>The information you are about to be referred to may not comply with the local regulatory requirements. Further information relevant to the local environment is available from the company or via the Product Information.</span></p>","continueText":"Continue","cancelText":"Cancel","exclusionUrls":["http://gsk.com/","https://www.gsk.com","https://innovation.gsk.com/","https://www.gskgrants.com","https://www.gskforyou.com/","https://www.gsk-clinicalstudyregister.com/","https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","http://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","https://www.gsk.com/en-gb/products/stiefel-dermatology/","https://www.gsk.com/en-gb/products/viiv-healthcare/","https://www.contactus.gsk.com/callback/index.html","https://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=Home&amp;entryPoint=adirect&amp;messageType=Home","https://www.gsksource.com/pharma/content/gsk/source/us/en.html","http://www.msds-gsk.com/","https://www.gsk.com/en-gb/investors/shareholder-information/","http://www.gsk.com/en-gb/investors/","https://www.gsk.com/en-gb/investors/corporate-reporting/","https://www.gsk.com/en-gb/investors/product-pipeline/","http://www.gskgrants.com/","https://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=Home&entryPoint=adirect&messageType=Home","https://www.gsk.com/media/2941/human-rights-statement-policy.pdf","http://www.gsk.com/media/280848/human-rights-statement-policy.pdf","https://www.gsk.com/en-gb/business-to-business/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","https://www.gsk.com/en-gb/business-to-business/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","http://twitter.com/GSK","http://www.gsk-clinicalstudyregister.com/","https://www.gsk.com/en-gb/media/press-releases/new-multi-country-survey-reveals-need-for-improved-awareness-around-long-term-impact-and-appropriate-use-of-corticosteroids-in-sle-management/","http://www.gskforyou.com/","https://www.gskforyou.com/prescription-resource-assistance/immunology-respiratory/","https://www.contactus.gsk.com/callback.html","https://www.gsk.com/en-gb/about-us/governance/global-compliance/","https://www.gsk.com/en-gb/careers/physicians/","https://www.gsk.com/en-gb/contact-us/worldwide/","https://access.gsk.com/password/","https://access.gsk.com/selfservice/static/login.jsp?TYPE=33554433&REALMOID=06-c7edf5ec-5585-100d-83b1-84797f88fc89&GUID=&SMAUTHREASON=0&METHOD=GET&SMAGENTNAME=-SM-90R5K5a0NsTyKRhPyTIn3A3B5ovKkqcehflGRUrUNusjZdRaPY%2bWUozEFizs1bMg&TARGET=-SM-https%3a%2f%2fuksah%2egsk%2ecom%2fswh_uk_win_ns%2fcommunications%2femployee%2femployees%2ehtm","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","https://ascend.cvmsolutions.com/Account/Login?client=gsk","https://www.gsk.com/media/5097/our-approach-to-responsible-business_sept-18.pdf","https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/","https://www.gsk.com/media/2538/gsk-materiality-process.pdf","https://www.gsk.com/en-gb/responsibility/access-to-healthcare/","https://www.gsk.com/en-gb/responsibility/our-people/","https://www.gsk.com/en-gb/responsibility/environment/","https://www.gsk.com/en-gb/responsibility/operating-responsibly/","https://www.gsk.com/media/4552/our-code-of-practice.pdf","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=10","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=35","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=35","https://www.gsk.com/en-gb/media/resource-centre/","https://www.gsk.com/en-gb/media/image-and-video-library/","https://www.gsk.com/en-gb/media/rss-feeds/","https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2017/","https://www.gsk.com/en-gb/careers/experienced-professionals/business-operations/","https://www.gsk.com/en-gb/careers/experienced-professionals/engineering/","https://www.gsk.com/en-gb/careers/experienced-professionals/manufacturing-and-supply/","https://www.gsk.com/en-gb/careers/experienced-professionals/marketing-and-communications/","https://www.gsk.com/en-gb/careers/experienced-professionals/research-and-development/","https://www.gsk.com/en-gb/careers/experienced-professionals/sales/","https://www.gsk.com/media/5041/rd-update-slides-hal-barron.pdf","https://www.gsk.com/en-gb/careers/meet-our-people/","https://www.gsk.com/en-gb/responsibility/our-people/employee-volunteering/","https://gskearlytalent.avature.net/landingpage","https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","https://www.gsk.com/en-gb/responsibility/our-people/volunteer-stories/","https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/","https://www.gsk.com/en-gb/research/our-approach/open-innovation/","https://www.youtube.com/channel/UChWuz9ZDceHYHXmJVJ4hF8Q","https://www.youtube.com/channel/UCN1XeWQWLVhFLHQwZl93jFQ","https://www.youtube.com/channel/UCwQyIfV4pLlsZGuN7fiZm2w","https://www.gsk.com/en-gb/media/press-releases/karenann-terrell-appointed-chief-digital-technology-officer-gsk/","https://www.gsk.com/en-gb/careers/meet-our-people/lindsay-rd-uk/","http://uk.gsk.com/en-gb/careers/apprenticeships/","https://www.gsk.com/media/4931/gsk-quick-facts.pdf","https://ie.gsk.com/ie/careers/apprenticeships/","http://au.gsk.com/en-au/careers/apprenticeships/","http://sg.gsk.com/en-sg/careers/","https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/","https://gsk.i-sight.com/landing-page/","https://www.gskforyou.com/","https://privacy.gsk.com/en-ca/privacy-notice/general","http://annualreport.gsk.com/","https://privacy.gsk.com","https://www.gsk.com/en-gb/company/outstanding-people/","https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-fy-2021-reported-sales-of-34-billion-stable-at-aer-plus5-cer/","https://www.gsk.com/media/7473/esg-performance-report-2021.pdf","https://www.gsk.com/en-gb/behind-the-science/","https://gskpro.com/","https://viivhealthcare.com/","https://gsk.supplierone.co/","https://www.gsk.com/speakup","https://www.gsk.com/en-gb/company/board-of-directors-and-leadership-team/","https://www.gsk.com/en-gb/research-and-development/our-approach-to-rd/","https://www.gsk.com/en-gb/innovation/partnerships/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/infectious-diseases/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/hiv/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/oncology/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/immunology/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/opportunity-driven/","https://www.gsk.com/media/8519/the-code-printable-version.pdf","https://www.gsk.com/en-gb/company/policy-positions","https://www.gsk.com/en-gb/company/codes-standards-and-reports","https://www.gsk.com/en-gb/innovation/pipeline/","https://www.gsk.com/en-gb/innovation/rd-locations/","https://www.gsk.com/en-gb/innovation/research-and-development-approach/","https://www.gsk-studyregister.com","https://gskpro.com/en-ca/","https://www.gsk.com/en-gb/responsibility/global-health-and-health-security/","https://www.gsk.com/en-gb/responsibility/pricing-and-access/","https://www.gsk.com/en-gb/responsibility/global-health-and-health-security/","https://www.gsk.com/en-gb/responsibility/diversity-equity-and-inclusion/","https://www.gsk.com/en-gb/responsibility/environmental-sustainability/","https://www.gsk.com/en-gb/responsibility/product-governance/","https://www.gsk.com/en-gb/responsibility/ethical-standards/","https://annualreport.gsk.com/","https://www.gsk.com/en-gb/media/media-contacts/","https://www.gsk.com/en-gb/media/media-library/","https://www.gsk.com/en-gb/media/social-media/","https://www.gsk.com/en-gb/media/our-response-to-the-situation-in-ukraine/","https://www.gsk.com/en-gb/careers/featured-careers/","https://www.gsk.com/en-gb/careers/how-we-hire/","https://www.gsk.com/en-gb/careers/our-global-and-regional-hubs/","https://www.gsk.com/en-gb/careers/how-we-hire/frequently-asked-questions/","https://www.gsk.com/en-gb/careers/","https://www.gsk.com/en-gb/careers/early-talent/kickstart-your-career/","https://www.gsk.com/en-gb/careers/early-talent/apprentice-programmes/","https://www.gsk.com/en-gb/careers/early-talent/work-experience-placements-and-internships/","https://www.gsk.com/en-gb/company/governance/compliance/","https://gskpro.com","https://www.gsk-studyregister.com/","https://www.gsk.com/en-gb/company/gsk-at-a-glance/","https://www.gsk.com/en-gb/innovation/technologies/","https://www.gsk.com/en-gb/innovation/trials/diversity-in-clinical-trials/","https://www.gsk.com/en-gb/responsibility/","https://www.gsk.com/en-gb/careers/early-talent/future-leaders-graduate-programme","https://privacy.gsk.com/en-ca/privacy-notice/","https://us.gsk.com/en-us/about-us/us-community-partnerships/stem-education/philadelphia-stem-equity-collective/","https://www.gsk.com/en-gb/responsibility/charitable-partnerships/","https://supplier.gsk.com/irj/portal/public","https://privacy.gsk.com/en-ca/privacy-notice/general/","https://twitter.com/gskca","https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-strong-2022-performance-with-full-year-sales-of-293-billion/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/respiratoryimmunology/","https://www.gsk.com/en-gb/investors/financial-reports/annual-report-2023/","https://www.gsk.com/en-gb/responsibility/environment/climate/","https://supplier.gsk.com/"]},"settings":{"optionalStylesheetLink":"/media/bbcob5qx/optional_style_ca.css","themeColorHexCode":null,"headerLogoLightTheme":null,"headerLogoDarkTheme":null,"footerLogo":{"src":"https://ca.gsk.com/media/s3hkylbc/gsk-logo_png.png?width=104&format=webp&quality=100&v=1dbf19a937d1f70","alt":"Gsk Logo Png","darkModeSrc":"https://ca.gsk.com/media/s3hkylbc/gsk-logo_png.png?width=104&format=webp&quality=90&v=1dbf19a937d1f70"},"scripts":[{"pageLocation":"Top","text":"<!-- Loading script asynchronously -->  \n<script type='text/javascript'>  (function(a,b,c,d){     a='//tags.tiqcdn.com/utag/gsk/profile-rx-ca/prod/utag.js' ; b=document;c='script';d=b.createElement(c);d.src=a;d.type='text/java'+c;d.async=true;    a=b.getElementsByTagName(c)[0];a.parentNode.insertBefore(d,a);  })();  </script>"}],"globalWebsiteLink":{"text":"Global","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"googleMapsApiKey":"AIzaSyA2QMg4Ww6djPKb7b9BraQn4kgJmDaLblg","textToSpeechApiKey":"","bingVerificationCode":"","googleAnalytics":"","siteTitle":" | GSK Canada"},"pageSettings":{"disableBackToTopButton":false,"backToTopButtonText":"Back to top","robotsNoFollow":false,"robotsNoIndex":false,"canonicalUrl":"https://ca.gsk.com/en-ca/media/press-releases/new-target-for-hiv-immune-therapy-and-cure-to-be-explored-by-trans-atlantic-industry-academia-collaboration/"},"tealiumSettings":{"enabled":false,"data":""},"entryPopup":null,"protectedPage":false,"schema":null}